Filter
720
Filtered Results: 720
Text search:
Licensed
pharmaceutical
products
Featured
Recommendations
65
New Publications
182
Language
Document type
No document type
293
Studies & Reports
191
Guidelines
112
Manuals
60
Strategic & Response Plan
40
Training Material
9
Fact sheets
9
Situation Updates
5
Resource Platforms
1
Countries / Regions
Global
39
Kenya
30
Nigeria
17
India
17
South Africa
14
Uganda
14
Ethiopia
14
Ghana
13
Western and Central Europe
12
Liberia
12
Sierra Leone
11
Rwanda
10
Latin America and the Carribbean
10
Zimbabwe
9
Philippines
9
Tanzania
9
Nepal
8
Ukraine
8
Zambia
8
Eastern Europe and Central Asia
7
Bangladesh
7
Malawi
6
Africa
6
Namibia
6
Myanmar / Burma
6
Syria
5
West and Central Africa
5
South–East Asia Region
5
East and Southern Africa
5
Thailand
4
Cambodia
4
Botswana
4
Benin
3
Laos
3
Senegal
3
Asia
3
Middle East and North Africa
3
Indonesia
3
Eswatini/ Swaziland
3
North Macedonia
2
Tajikistan
2
Cameroon
2
Burkina Faso
2
Mozambique
2
Congo, Democratic Republic of
2
Western Pacific Region
2
North America
2
United Kingdom
2
Eastern Europe
2
Timor Leste/ East Timor
1
Serbia
1
Lesotho
1
Kazakhstan
1
Iran
1
Albania
1
Kyrgyzstan
1
Uzbekistan
1
Mongolia
1
Bulgaria
1
Guinea
1
Armenia
1
Haiti
1
Venezuela
1
Gabon
1
Vietnam
1
Brazil
1
Moldova
1
Russia
1
Sudan
1
Georgia
1
Mali
1
Angola
1
South Sudan
1
Somalia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
267
Clinical Guidelines
68
Public Health
49
Key Resources
27
Pharmacy & Technologies
25
Women & Child Health
21
Capacity Building
5
Toolboxes
AMR
83
Pharmacy
71
COVID-19
47
NTDs
32
Mental Health
30
HIV
28
TB
27
Planetary Health
23
Health Financing Toolbox
19
Caregiver
18
Global Health Education
17
Conflict
15
Rapid Response
13
NCDs
13
Malaria
12
2.0 Rapid Response
10
Ebola & Marburg
9
Specific Hazards
5
Refugee
3
Disability
3
Polio
2
Natural Hazards
1
Social Ethics
1
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...
Annex 5, WHO Technical Report Series 1010, 2018
Prices people pay for medicines.
Médecins sans Frontières access campaign
Issue Brief
Accessed: 28.11.2019
As of December 2018, CEPI has secured more than USD $747million towards its USD $1billion funding target, with financial support provided by the Bill & Melinda Gates Foundation, the Wellcome Trust, the European Commission, and the governments of Australia, Belgium, Canada, Germany, Japan, Norway, an...
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. I...
The ethical governance of research assumes the existence of a national entity (or subnational if applicable, according to the constitution of a country) in charge of supervising the research ethics committees (RECs) that review and monitor research with human beings. This supervision includes the ac...
Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and public health relevance, evidence of efficacy and safety and comparative cost-effectiveness. They are intended to be available in functioning health ...
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
Med J DY Patil Univ 2017;10:229-33
The WHO Model List of Essential Medicines and Model List of Essential Medicines for Children are updated and published every two years, intended as a guide for countries or regional authorities to adopt or adapt in accordance with local priorities and treatment guidelines for the development and upd...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
